# The aim of the present multicenter study was to assess quality of life of Dutch dialysis patients 3 months after the start of chronic dialysis treatment. The quality of life was compared with the quality of life of a general population sample, and the impact of demographic, clinical, renal function, and dialysis characteristics on patients' quality of life was studied. New end-stage renal disease (ESRD) patients who were started on chronic hemodialysis or peritoneal dialysis in 13 dialysis centers in The Netherlands were consecutively included. Patients' self-assessment of quality of life was measured by the SF-36, a 36-item Short Form Health Survey Questionnaire encompassing eight dimensions: physical functioning, social functioning, role-functioning physical, role-functioning emotional, mental health, vitality, bodily pain, and general health perceptions. One hundred twenty hemodialysis and 106 peritoneal dialysis patients completed the SF-36. Quality of life of hemodialysis and peritoneal dialysis patients was substantially impaired in comparison to the general population sample, particularly with respect to role-functioning physical and general health perceptions. Mean role-functioning physical and general health perceptions scores of the hemodialysis patients corre sponded with the lowest scoring 8% and 12%, respectively, of the reference group. Mean role-functioning physical and general health perceptions scores of the peritoneal dialysis patients corresponded with the lowest scoring 10% and 12%, respectively, of the reference group. Hemodialysis patients showed tower levels of quality of life than peritoneal dialysis patients on physical functioning, role-functioning emotional, mental health, and pain. However, on the multivariate level, we could only demonstrate an impact of dialysis modality on mental health. A higher number of comorbid conditions, a lower hemoglobin level, and a lower residual renal function were independently related to poorer quality of life. The variability of the SF-36 scores explained by selected demographic, clinical, renal function, and dialysis characteristics was highest for physical functioning (29.7%). Explained variability of the other SF-36 dimensions ranged from 6.9% for general health perceptions to 15.4% for vitality. We conclude that quality of life of new ESRD patients is substantially impaired. Comorbid conditions, hemoglobin, and residual renal function could explain poor quality of life only to a limited extent. Further research exploring determinants and indices of quality of life in ESRD patients is warranted. From a clinical perspective, we may conclude that quality of life should be considered in the monitoring of dialysis patients. © 1997 by the National Kidney Foundation, Inc. INDEX WORDS: End-stage renal disease; chronic dialysis; quality of life.
© 1997 by the National Kidney Foundation, Inc.
0272-6)386/97/2904-0015$3.00/0
and social functioning.1 Studies comparing qual ity of life between dialysis patients and general population samples have not yielded conclusive results. Some studies have found quality of life of dialysis patients to be inferior to quality of life of the general population2'6; others,7'0 how ever, have not observed a difference. In addition, comparisons of quality of life between hemodial ysis and peritoneal dialysis did not indicate one of these to be clearly superior.1 "'15 These incon sistent results may have been caused by small sample sizes and the cross-sectional study design of these studies. The latter leads to heterogeneous treatment groups with respect to the duration of therapy and a divergent therapy history. In addi tion, insufficient control of background charac teristics and the use of different definitions and assessment methods of quality of life may have attributed to the inconsistent results, Finally, it recently became clear that use of recombinant human erythropoietin significantly improves quality of life.K),t7 Therefore, the results of stud-ies conducted before the availability of erythro poietin that did not adjust for the level of anemia are questionable.
Quality-of-life assessment in reasonable num bers of chronic dialysis patients with a multidi mensional, reliable, and validated instrument is needed. In studies from the United States, the United Kingdom, and The Netherlands, the 36item Short Form Health Survey Questionnaire (SF-36) has been found to satisfy these require ments.!H "21 Moreover, the SF-36 recently has been shown to be applicable to dialysis patients,2"5 However, these latter studies were conducted in limited patient groups, and no adjustment was made for patient and dialysis characteristics.
The aim of the present multicenter study was to assess quality of life, using the SF-36, of Dutch patients with end-stage renal disease (ESRD) who were newly started on chronic dialysis treatment. The quality of life of these patients was compared with the quality of life of a general population sample, and demographic, clinical, re nal function, and dialysis characteristics, associ ated with quality of life, were identified.
PATIENTS AND METHODS

Patients and Procedures
Between October 1, 1993, and April 1, 1995, new ESRD patients aged 18 years who were started on chronic hemodi alysis or peritoneal dialysis in 13 Dutch dialysis centers were consecutively included, These 13 dialysis centers comprise 27% of the total number of dialysis centers that treat adult patients in The Netherlands,
The following major categories of data were analyzed: demographic, clinical, renal function, dialysis, and quality of life. These data were collected from each subject 3 months after the start of chronic dialysis treatment. The choice for performing all measurements at 3 months was made because the mode of dialysis treatment usually has stabilized by this time. Hence, measurements at 3 months are less likely to be influenced by metabolic instability than at the initiation of treatment.
Demographic, Clinical, Renal Function, and sis xic (eristics
Demographic variables s tut lied were age, sex, marital sta tus, level of education, and employment staLus. Clinical char acteristics comprised primary kidney disease, comorbidity» use of erythropoietin, hemoglobin, and serum albumin con centration, Renal function and dialysis characteristics com prised residual renal function, dose of dialysis in terms of dialysis-related urea clearance, and protein catabolic rate (PCR).
Primary kidney disease was classified according to the European Dialysis and Transplantation Association-European Renal Association registry, " Renal vascular disease" refers to renal vascular disease excluding vasculitis and comprises the following subcategories: renal vascular ciisea.se, type un specified; renal vascular disease due to malignant hyperten sion (no primary renal disease); renal vascular disease due to hypertension (no primary renal disease); and renal vascular disease, classified. Comorbidity was defined in terms of pres ence of nonrenal diseases at the time of commencing renal replacement therapy or in the medical history. It was divided into three major categories: cardiovascular comorbidity, dia betes mellitus, and malignancy. In addition, the total number of comorbid conditions was calculated for each patient. Residual renal Function (residual glomerular IIliration rate IrGFR]) was calculated as the mean renal clearance of urea and creatinine. The removal of urea by dialysis was expressed as the dialysis Kt/VU rtsn. In the hemodialysis patients, dialysis Kt/Vlirei, was calculated by the equation of Daugirdas.22 To obtain the weekly Kt/Vunjn, this number was multiplied by the number of treatments per week, The volume of distribution of urea (V) was estimated as 55% of body weight. This estima tion also was used in all other calculations, in the peritoneal dialysis patients, dialysis Kt/Vuri> " was calculated as the perito neal Ki7Vurun per 24 hours multiplied by 7. The normalized PCR (nPCR) was calculated according to Daugirdas22 in the hemodialysis patients. In the peritoneal dialysis patients, it was calculated as normalized protein nitrogen appearance (nPNA) according to the equation of BergstrOm et al, The nPCR and nPNA reflect the protein intake in metabolically stable patients. The hemodialysis patients collected ail urine during an interdialytic interval. Blood samples were taken before and after the dialysis preceding this interval and at the end of this interval. The peritoneal dialysis patients collected urine and dialysate during a 24-hour period. A blood sample was taken during the collection period. Urea and creatinine in the plasma, urine, and peritoneal dialysate were determined.
Qua!ity-of-Life Assessment
Patients' self-assessment of quality of life was measured by theMOS SF-36.IH '21 The SF-36 is a generic multidimensional instrument consisting of eight multi-item scales representing (1) physical functioning (extent to which health limits physi cal activities, such as self-care, walking, and climbing stairs), (2) social functioning (extent to which physical health or emotional problems interfere with normal social activities), (3) role-functioning physical (extent to which physical health interferes with work or other daily activities), (4) role-funelioning emotional (extent to which emotional problems inter fere with work or other daily activities)» (5) mental health (general mental health, including depression, anxiety, belutvioral-emotional control, and general positive effect), (0) vital ity (feeling energetic and full of pep rather than tired and worn out), (7) bodily pain (intensity of pain and effect of pain on normal work, both inside and outside the home), and (8) general health perceptions (personal evaluations of current health, health outlook, and resistance to illness). The SF-36 scores of our ESRD population were compared with the SF-36 scores of a general Dutch population sample (n = 1,063; age range, 18 to 89 years; 35% male) as described by van der Zee et nl.21 SF-36 scores were transformed to a scale of Hemoglobin (g/dL),* mean ± SD (range) 9.9 ± 1.4(5.9-14.0) 11.2 ± 1.4 (7.6-14.3) Serum albumin (g/dL), mean ± SD (range) 3 'V .V i.V Either /-statistics or chi-square statistics (Fisher's exact test, when appropriate) were applied for independent group comparisons. Differences between I he mean SF-36 scores of the hemodialysis and peritoneal dialysis patients with those of the reference population were convened to mean standard scores. Standard scores were calculated by dividing the differ ence between a given mean SF-36 score of the dialysis group and the mean SF-36 score in the reference group by the standard deviation of SF-36 scores in the reference group. The standard scores indicate how many standard deviations the observed SF-36 scores of dialysis patients fall below the scores of the reference population (with the scores of the reference population set at zero). Univariate relationships be tween demographic, clinical, renal function, and dialysis characteristics on the one hand, and SF-36 scores on the other hand were assessed by Student's /-test, one-way ANOVA, or Pearson's correlation coeflicient. As values of dialysisrelated urea clearance are not equal by technique origin, uni variate relations were assessed for each treatment modality separately. All .significant characteristics (set at P ^ 0.20) identified from univariate analysis were studied with multiple linear regression (with a stepwise forward selection strategy), using the F-stalistics with P 0.05 as the criterion level for selection. To search for violations of necessary assumptions in multiple regression, normal plots of the residuals of the regression models were produced. Furthermore, the inlluence of outliers (Cook's distances) anil possible presence of col lin earity (Tolerance/Variance Inflation Factor statistics) were assessed. All analyses were made with SAS for Windows 6.10 (SAS Institute Inc, Cary, NC).
RESULTS
Characteristics o f Participants and Nonparticipants
Two hundred fifty ESRD patients were avail able for the study. Of these patients, 226 (90.4%) completed the SF-36. Twenty-four patients did not complete the SF-36 because they did not speak the Dutch language sufficiently and/or were not able to read and till out the question naire by themselves. Except for a lower propor tion of males and a lower hemoglobin level (P < 0.05), nonparticipants were comparable to the participants. In the participating hemodialysis pa tients, mean age was slightly higher, employment rate was lower, prevalence of malignancy was higher, dialysis-related Kt/Vuren was higher, and nPCR was lower than in the participating perito neal dialysis patients (P < 0,05; Table 1 ).
Comparison o f Quality o f Life Between the End-Stage Renal D isease Patients and a General Population Sample
In Table 2 , mean SF-36 scores of the ESRD patients according to treatment modality and the general population sample are shown. Both hemodialysis and peritoneal dialysis patients perceived their quality of life as worse than the general population sample on all quality-of-life dimensions, particularly on the role-function ing physical and general health perceptions di mensions. Figure I shows the differences be tween the dialysis patients and the reference group expressed in standard scores. Mean rolefunctioning physical scores of the hemodialysis and peritoneal dialysis patients were 1.4 and 1.3 SD below the values of the reference group. Mean general health perception scores of he modialysis and peritoneal dialysis patients were 1.3 and L 2 SD below the values of the reference group. In other words, mean rolefunctioning physical scores of the hemodialy sis patients and the peritoneal dialysis patients corresponded to the lowest scoring 8% and 10% of the reference group, respectively. Simi larly, mean general health perceptions scores of the hemodialysis and peritoneal dialysis pa tients corresponded to the lowest scoring 10% and 12% of the reference population, respec tively. Hemodialysis patients demonstrated an impaired quality of life compared with perito neal dialysis patients with respect to physical functioning, role-functioning emotional, men tal health, and bodily pain ( Table 2) .
Associations Between D em ographic, Clinical, Renal Function, and D ialysis Characteristics and Quality o f Life
Univariate associations between SF-36 scores and demographic, clinical, renal function, and dialysis characteristics are shown in Tables 3 and  4 . Of the demographic characteristics, higher age and unemployment were associated with lower levels of quality of life on most subdimensions. None of the SF-36 scores differed between mar ried and unmarried patients. With respect to the clinical characteristics, a lower hemoglobin and an increasing number of comorbid conditions correlated with decreasing quality-of-Iife scores. Patients with cardiovascular comorbidity scored lower on physical functioning, vitality, and gen eral health perceptions than patients without this condition. Diabetes mellitus was associated with worse physical functioning. Patients with malig nant comorbid conditions reported higher levels of pain than patients without malignancy. Pa tients with renal vascular disease or multisystem disease as the primary cause of renal failure re ported lower levels of social functioning and vi tality than patients with other underlying causes. Of parameters of renal function and dialysis ade quacy, a lower rGFR correlated with poorer qual ity of life on live subdimensions. The nPCR/ nPNA only correlated with worse physical func- (Table 5 ). However, a higher number of comorbid conditions, a lower hemoglobin, and a lower rGFR remained associ ated with poorer quality-of-lile scores, With re spect to dialysis modality, an effect on mental health persisted in favor of peritoneal dialysis. In addition, on the multivariate level, higher age and unemployment remained only related to lower levels of quality of life on two subdimen sions. Primary kidney disease showed only an association with lower vitality, attributable to pa tients with renal vascular disease. Finally, lower nPCR/nPNA levels were associated with worse quality of life with respect to physical function ing and bodily pain. The selected characteristics explained only a small proportion of the variabil ity (R~) of the SF-36 scores: 6.9% to 29.7% (Ta ble 5). 
D IS C U S S IO N
New ESRD patients" assessment of quality of life was observed to be lower than that of a gen eral population sample on all distinguished quality-of-life dimensions. Because the mean age of the reference group (44 years) was lower and because SF-36 scores are negatively related with age,21 this might have resulted in a slight overes timation of the difference 111 quality of life. When scores of the ESRD population were compared with those of the subgroup of the reference popu lation aged 55 to 64 years (n = 140), scores of both hemodialysis and peritoneal dialysis pa tients were still significantly lower, with the ex ception of bodily pain in peritoneal dialysis pa tients, In agreement with our finding, some recent studies2* 5 observed SF-36 scores of ESRD pa tients to be lower than scores of a general popu lation sample. On the contrary, other investiga tors7-9 have reported a comparable quality of life for ESRD patients and general population sam ples.
Multivariate analysis showed that a higher number of comorbid conditions, a lower hemo globin level, and a lower residual renal function (rGFR) were the most important independent ex planatory factors for poorer quality of life. The present study is, to our knowledge, the first to link residual renal function and amount of dial ysis to quality of life. The finding that patients with a lower rGFR reported a worse quality of life, while no effect of dialysis Kt/Vlllca could be demonstrated, might suggest that clearance achieved by the native kidneys is superior to clearance obtained by dialysis. This could be caused by the fact that more rGFR will be accom panied by bettei* tubular secretion of, for exam ple, organic acids and a better preserved hor monal function. In addition, deteriorating residua! renal function may give rise to a worse perception of quality of life by a growing aware ness of complete dependence on dialysis, Our finding of a negative influence of a higher num ber of comorbid conditions and a lower level of hemoglobin concentration on quality of life is in accordance with former studies.*'10,1(07 Notably, the total explained variation of qual ity of life by the selected characteristics was small. This suggests that quality of life is deter mined by many more factors than the ones we have assessed in this study. It is reasonable to assume that the patients" level of quality of life is a result of a complex interaction of disease outcome, personal traits, coping behavior, social support, and quality of the care received.
Comparison of quality of life between the present dialysis groups indicated peritoneal dial ysis to be superior only with respect to mental health. However, the explained variation by dial ysis modality was only 6%. The similarity of both dialysis groups with respect to quality of life may be due to the foot that all patients had just started on dialysis treatment. It can be postu lated that in the early phase, perceived quality of life is more affected by the dependence on dial ysis treatment than by the modality of treatment. Comparison of our results with previous compar isons of quality of life between different dialysis modalities did not yield a conclusive answer. In two large cross-sectional studies, no differences in perceived quality of life were detected be tween hemodialysis and peritoneal dialysis pa tients, after adjustment for some demographic characteristics, comorbidity status, and duration of treatment.8,10 In addition, Tucker et al14 found no difference in perceived quality of life between peritoneal dialysis and hemodialysis patients. Simmons et al,6 however, observed peritoneal di alysis patients to report a more favorable out come than hemodialysis patients in terms of physical well-being, emotional adjustment, and vocational rehabilitation. Additionally, in a com parison of quality of life of peritoneal dialysis and hemodialysis patients, matched for age, sex, race, diabetes, and duration of renal replacement therapy (regardless of modality), peritoneal dial ysis appeared to be somewhat superior with re gard to psychological and social rehabilitation.15 O11 the other hand, Griffin et al12 observed that hemodialysis patients were not more impaired in terms of functional status and showed better psychological adjustment compared with perito neal dialysis patients. However, hemodialysis pa tients had received dialysis treatment for a sig nificantly longer period of time than the peritoneal dialysis patients (52 months v 29 months), and therefore may have had more time to adjust their lifestyle and emotional reactions.
The inconsistent results in the literature may be explained by cross-sectional samples, small sample sizes, and improper adjustment for case QUALITY OF UFE OF CHRONIC DIALYSIS PATIENTS 591 mix. Although some of the described studies ad justed for demographic variables, comorbidity, and length of dialysis therapy, heterogeneity re garding prior history of renal replacement ther apy, like therapy turnover, has been hardly taken into account. It may be easily understood that a history of little or many therapy failures deter mines one's current assessment of quality of life.
'eover, application of different perspectives of quality of life assessed with a variety of quality-of-life instruments can also explain this in conclusive picture. This is illustrated by Deniston et al, who assessed quality of life of a crosssectional sample of 742 ESRD patients from Michigan with 19 different quality-oi-life instru ments. Depending on the choice of instrument, different conclusions were reached about the re lationship between demographic characteristics and quality of life.
In conclusion, the present findings indicate that in new ESRD patients, quality of life is sub stantially impaired. Comorbidity, hemoglobin level, and residual renal function could explain variations in quality of life only to a limited ex tent. Therefore, other potential determinants of quality of life should be explored. In addition, health indices other than the SF-36 should be examined. Perhaps we should focus more on dis ease-targeted indices, such as renal disease and dialysis-related problems as perceived by the pa tient, Furthermore, longitudinal data are needed to obtain insight into the long-term effects of chronic dialysis treatment on patients' quality of life. We will elaborate on these issues in our future analyses. From a clinical perspective, we conclude that quality-of-life assessment should be considered in the monitoring of a dialyis pa tient as it seems that quality of life cannot be extrapolated from conventional clinical characteristies.
